{
  "id": 3680,
  "text": "1680.Morris, M., Blessing, J.A., Monk, B.J., McGehee, R.& Moore, D.H.Phase II study of cisplatin and vinorelbine in squamous cell carcinoma of the cervix: a gynecologic oncology group study.J Clin Oncol 22, 3340-3344 (2004).",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 1680.Morris, M., Blessing, J.A., Monk, B.J., McGehee, R.& Moore, D.H.Phase II study of cisplatin and vinorelbine in squamous cell carcinoma of the cervix: a gynecologic oncology group study.J Clin Oncol 22, 3340-3344 (2004).\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "在这项发表于2004年的研究中，研究探讨了顺铂（cisplatin）和长春瑞滨（vinorelbine）联合使用在宫颈鳞状细胞癌患者中的应用。这是一项二期临床试验，目的是评估这种联合化疗方案的有效性和安全性，旨在为宫颈鳞状细胞癌提供更有效的治疗选择。",
  "query": "这项发表在2004年的研究探讨了哪些治疗方案在宫颈鳞状细胞癌患者中的应用？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 这项发表在2004年的研究探讨了哪些治疗方案在宫颈鳞状细胞癌患者中的应用？\n\n<reference text>: 1680.Morris, M., Blessing, J.A., Monk, B.J., McGehee, R.& Moore, D.H.Phase II study of cisplatin and vinorelbine in squamous cell carcinoma of the cervix: a gynecologic oncology group study.J Clin Oncol 22, 3340-3344 (2004).\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "在这项发表于2004年的研究中，研究探讨了顺铂（cisplatin）和长春瑞滨（vinorelbine）联合使用在宫颈鳞状细胞癌患者中的应用。这是一项二期临床试验，目的是评估这种联合化疗方案的有效性和安全性，旨在为宫颈鳞状细胞癌提供更有效的治疗选择。"
}